|
US2788341A
(en)
|
1953-03-06 |
1957-04-09 |
Ciba Pharm Prod Inc |
Process for the manufacture of aminoacyl compounds
|
|
US3624097A
(en)
*
|
1969-07-22 |
1971-11-30 |
Warner Lambert Co |
N-pyridine 5-aminooxazoles
|
|
US4109496A
(en)
|
1977-12-20 |
1978-08-29 |
Norris Industries |
Trapped key mechanism
|
|
US4147343A
(en)
|
1978-02-25 |
1979-04-03 |
Hyde Phillip R |
Acrobatic amusement device
|
|
FR2568880B1
(fr)
|
1984-08-07 |
1986-12-12 |
Synthelabo |
Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
|
|
US4868103A
(en)
|
1986-02-19 |
1989-09-19 |
Enzo Biochem, Inc. |
Analyte detection by means of energy transfer
|
|
US5080891A
(en)
|
1987-08-03 |
1992-01-14 |
Ddi Pharmaceuticals, Inc. |
Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
|
|
DE68905707T2
(de)
|
1988-08-10 |
1993-08-19 |
Tokyo Sintered Metals Corp |
Fahrradaehnliches trainingsgeraet.
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
|
US6905680B2
(en)
|
1988-11-23 |
2005-06-14 |
Genetics Institute, Inc. |
Methods of treating HIV infected subjects
|
|
US6534055B1
(en)
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
|
US5858358A
(en)
|
1992-04-07 |
1999-01-12 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for selectively stimulating proliferation of T cells
|
|
US5016870A
(en)
|
1990-02-09 |
1991-05-21 |
Bulloch Russell G |
Exercise device
|
|
DE69210091T2
(de)
*
|
1991-05-31 |
1996-10-02 |
Sumitomo Pharma |
Leukotrien-B4-Antagonisten
|
|
EP0552108B1
(en)
|
1992-01-17 |
1999-11-10 |
Lakowicz, Joseph R. |
Energy transfer phase-modulation fluoro-immunoassay
|
|
JP3537141B2
(ja)
|
1992-10-30 |
2004-06-14 |
ザ ゼネラル ホスピタル コーポレーション |
新種蛋白質分離のための相互作用を用いる補捉システム
|
|
US5569128A
(en)
|
1994-02-03 |
1996-10-29 |
Icon Health & Fitness, Inc. |
Leg and upper body exerciser
|
|
US5656465A
(en)
|
1994-05-04 |
1997-08-12 |
Therion Biologics Corporation |
Methods of in vivo gene delivery
|
|
US7175843B2
(en)
|
1994-06-03 |
2007-02-13 |
Genetics Institute, Llc |
Methods for selectively stimulating proliferation of T cells
|
|
US7067318B2
(en)
|
1995-06-07 |
2006-06-27 |
The Regents Of The University Of Michigan |
Methods for transfecting T cells
|
|
US6692964B1
(en)
|
1995-05-04 |
2004-02-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for transfecting T cells
|
|
US5677158A
(en)
|
1995-06-07 |
1997-10-14 |
Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
|
US5801030A
(en)
|
1995-09-01 |
1998-09-01 |
Genvec, Inc. |
Methods and vectors for site-specific recombination
|
|
US6180612B1
(en)
|
1997-10-31 |
2001-01-30 |
The University Of Virginia Patent Foundation |
Methods and compositions for targeting DNA metabolic processes using aminoglycoside derivatives
|
|
US6683058B1
(en)
|
1998-04-15 |
2004-01-27 |
Regents Of The University Of California |
Methods for therapy of neurodegenerative disease of the brain
|
|
CA2329259C
(en)
|
1998-05-27 |
2003-08-05 |
Avigen, Inc. |
Convection-enhanced delivery of aav vectors
|
|
JP2000095767A
(ja)
|
1998-09-28 |
2000-04-04 |
Takeda Chem Ind Ltd |
性腺刺激ホルモン放出ホルモン拮抗剤
|
|
WO2000024392A1
(en)
*
|
1998-10-26 |
2000-05-04 |
Sumitomo Pharmaceuticals Company, Limited |
β-AMYLOID FORMATION INHIBITORS
|
|
DE60014339T8
(de)
|
1999-04-02 |
2006-04-27 |
Neurogen Corp., Branford |
Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren
|
|
CA2369553A1
(en)
|
1999-04-02 |
2000-10-12 |
Raymond F. Horvath |
N-benzimidazolylmethyl and n-indolylmethyl-benzamides and their use as crf modulators
|
|
US7205103B2
(en)
|
2000-02-11 |
2007-04-17 |
The Salk Institute For Biological Studies |
Method of regulating transcription in a cell
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
HK1052372A1
(zh)
|
2000-02-24 |
2003-09-11 |
Xcyte Therapies, Inc. |
细胞的同步刺激和富集
|
|
US6867041B2
(en)
|
2000-02-24 |
2005-03-15 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US6547702B1
(en)
|
2000-03-29 |
2003-04-15 |
Innovative Applications, Inc. |
Exercise device
|
|
EP1301214A2
(en)
|
2000-05-26 |
2003-04-16 |
Chiron Corporation |
Methods of transducing neural cells using lentivirus vectors
|
|
WO2002020737A2
(en)
|
2000-09-07 |
2002-03-14 |
Vanderbilt University |
Genome engineering by cell-permeable dna site-specific recombinases
|
|
US6551786B2
(en)
|
2001-01-04 |
2003-04-22 |
Myriad Genetics, Inc. |
Screen assay for selecting protein-protein interaction modulators
|
|
JP2003033179A
(ja)
|
2001-07-05 |
2003-02-04 |
Asahi Kasei Corp |
可逆的遺伝子導入ベクター
|
|
JP2003077651A
(ja)
|
2001-08-30 |
2003-03-14 |
Sharp Corp |
有機エレクトロルミネッセンス素子の製造方法
|
|
EP1434579B1
(en)
|
2001-10-09 |
2011-06-08 |
Amgen Inc. |
Imidazole derivatives as antiinflammatory agents
|
|
US20050079512A1
(en)
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
|
WO2004078939A2
(en)
|
2003-03-03 |
2004-09-16 |
University Of Massachusetts |
REGULATION OF Mdm2 FUNCTION
|
|
US20050130919A1
(en)
|
2003-07-18 |
2005-06-16 |
University Of Massachusetts |
Regulatable promoters for synthesis of small hairpin RNA
|
|
AU2004283053A1
(en)
|
2003-10-20 |
2005-05-06 |
Nsgene A/S |
In vivo gene therapy of Parkinson's Disease
|
|
WO2005085443A2
(en)
|
2004-03-01 |
2005-09-15 |
Massachusetts Institute Of Technology |
Rnai-based therapeutics for allergic rhinitis and asthma
|
|
WO2005112620A2
(en)
|
2004-05-18 |
2005-12-01 |
Massachusetts Institute Of Technology |
A cre-lox based method for conditional rna interference
|
|
AU2005261487A1
(en)
|
2004-07-12 |
2006-01-19 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Amide derivatives as inhibitors of histone deacetylase
|
|
MX2007005611A
(es)
|
2004-11-11 |
2007-07-11 |
Ferrer Int |
Compuestos de imidazo[1,2-a]piridina, composiciones, usos y metodos relacionados.
|
|
WO2006070806A1
(ja)
|
2004-12-28 |
2006-07-06 |
Taiho Pharmaceutical Co., Ltd. |
新規ベンゾイミダゾール化合物及び該化合物を含有する医薬組成物
|
|
US20070105181A1
(en)
|
2005-05-04 |
2007-05-10 |
Invitrogen Corporation |
Identification of cancer biomarkers and phosphorylated pdroteins
|
|
BRPI0716583A2
(pt)
|
2006-08-24 |
2013-10-01 |
Australian Nuclear Science Tec |
ligandos fluorados para marcar recptores de benzodiazepina perifÉricos
|
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
PH12012502343A1
(en)
*
|
2007-05-23 |
2013-06-17 |
Siga Tech Inc |
Antiviral drugs for treatment or prevention of dengue infection
|
|
WO2008157500A1
(en)
|
2007-06-17 |
2008-12-24 |
Kalypsys, Inc. |
Aminoquinazoline cannabinoid receptor modulators for treatment of disease
|
|
US7927258B2
(en)
|
2007-08-17 |
2011-04-19 |
Real Ryder, LLC |
Bicycling exercise apparatus
|
|
AU2008345225A1
(en)
*
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
CA2618163A1
(en)
|
2008-02-07 |
2009-08-07 |
K. W. Michael Siu |
Head and neck cancer biomarkers
|
|
CA2716947A1
(en)
|
2008-02-29 |
2009-09-11 |
Array Biopharma Inc. |
Imidazo [4,5-b] pyridine derivatives used as raf inhibitors
|
|
EP2349484A2
(en)
*
|
2008-07-15 |
2011-08-03 |
Novartis AG |
Heteroaryl derivatives as dgat1 inhibitors
|
|
CA2751412A1
(en)
|
2009-02-05 |
2010-08-12 |
Targeted Delivery Technologies Limited |
Methods of reducing the proliferation and viability of microbial agents
|
|
CN103038231B
(zh)
|
2010-03-17 |
2016-04-20 |
泰纬生命科技股份有限公司 |
Hec1活性调节剂及其方法
|
|
EP2561351B1
(en)
|
2010-04-22 |
2015-12-09 |
British Columbia Cancer Agency Branch |
Novel biomarkers and targets for ovarian carcinoma
|
|
US20120035244A1
(en)
|
2010-07-29 |
2012-02-09 |
The Regents Of The University Of Michigan |
Parp1 targeted therapy
|
|
US9072052B2
(en)
|
2010-08-09 |
2015-06-30 |
Blackberry Limited |
Communication system providing context-based mobile wireless communications device power consumption management and related methods
|
|
US8647240B2
(en)
|
2010-10-08 |
2014-02-11 |
Innovative Applications, Inc. |
Exercise device
|
|
US9656959B2
(en)
|
2010-12-22 |
2017-05-23 |
Purdue Pharma L.P. |
Substituted pyridines as sodium channel blockers
|
|
WO2012138789A2
(en)
|
2011-04-04 |
2012-10-11 |
Netherlands Cancer Institute |
Methods and compositions for predicting resistance to anticancer treatment
|
|
EP2697368B1
(en)
|
2011-04-15 |
2019-06-05 |
Genelux Corporation |
Clonal strains of attenuated vaccinia viruses and methods of use thereof
|
|
US9403843B2
(en)
|
2012-02-01 |
2016-08-02 |
The Trustees Of Columbia University In The City Of New York |
Cysteine protease inhibitors and uses thereof
|
|
EP2809660B1
(en)
|
2012-02-02 |
2016-01-20 |
Ensemble Therapeutics Corporation |
Macrocyclic compounds for modulating il-17
|
|
US9227106B2
(en)
|
2012-05-21 |
2016-01-05 |
Todd Richards |
Weight lifting machine
|
|
ES2728782T3
(es)
|
2012-05-25 |
2019-10-28 |
Univ California |
Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
|
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
|
KR102955556B1
(ko)
|
2012-12-12 |
2026-04-22 |
더 브로드 인스티튜트, 인코퍼레이티드 |
서열 조작을 위한 crispr-cas 성분 시스템, 방법 및 조성물
|
|
CN105209621B
(zh)
|
2012-12-12 |
2021-05-25 |
布罗德研究所有限公司 |
对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
|
|
US9410943B2
(en)
|
2013-03-14 |
2016-08-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma
|
|
ES2900301T3
(es)
|
2013-03-15 |
2022-03-16 |
Novartis Ag |
Biomarcadores asociados con la inhibición de BRM
|
|
EP2968318A4
(en)
*
|
2013-03-15 |
2016-12-14 |
Shifa Biomedical Corp |
ANTI-PCSK9 COMPOUNDS AND METHODS FOR TREATING AND / OR PREVENTING CARDIOVASCULAR DISEASES
|
|
US10976320B2
(en)
|
2013-05-21 |
2021-04-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for identifying and treating cancer patients
|
|
JP6411342B2
(ja)
|
2013-07-03 |
2018-10-24 |
武田薬品工業株式会社 |
アミド化合物
|
|
US20160130663A1
(en)
|
2013-07-12 |
2016-05-12 |
National Cancer Center |
Method for predicting response to cancer treatment
|
|
EP3022197B1
(en)
|
2013-07-15 |
2017-09-06 |
Boehringer Ingelheim International GmbH |
Novel tetra- and pentasubstituted benzimidazolium compounds
|
|
WO2015046193A1
(ja)
|
2013-09-25 |
2015-04-02 |
塩野義製薬株式会社 |
Ｔｒｐｖ４阻害活性を有する芳香族複素環式アミン誘導体
|
|
US10266515B2
(en)
|
2013-12-30 |
2019-04-23 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
|
US9919998B2
(en)
|
2014-02-06 |
2018-03-20 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides
|
|
GB201402771D0
(en)
|
2014-02-17 |
2014-04-02 |
Isis Innovation |
Biomarker & therapeutic target for sarcoma
|
|
EP3177640B1
(en)
|
2014-08-08 |
2020-05-06 |
The Board of Trustees of the Leland Stanford Junior University |
High affinity pd-1 agents and methods of use
|
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
US9636323B2
(en)
|
2014-10-27 |
2017-05-02 |
Baylor College Of Medicine |
Method of treating cancer that overexpresses TopBP1
|
|
CN104530013B
(zh)
|
2014-12-04 |
2016-06-29 |
中国农业大学 |
基于吲哚环的吡唑酰胺类化合物作为农用杀菌剂的用途
|
|
US9546296B2
(en)
|
2014-12-15 |
2017-01-17 |
Ppg Industries Ohio, Inc. |
Coating compositions, coatings and methods for sound and vibration damping and water resistance
|
|
US9932340B2
(en)
|
2014-12-18 |
2018-04-03 |
Abbvie Inc. |
Substituted indoles
|
|
JP6815318B2
(ja)
|
2014-12-23 |
2021-01-20 |
ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド |
二官能性分子によって標的化タンパク質分解を誘導する方法
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
MA41598A
(fr)
|
2015-02-25 |
2018-01-02 |
Constellation Pharmaceuticals Inc |
Composés thérapeutiques de pyridazine et leurs utilisations
|
|
WO2016160718A1
(en)
*
|
2015-03-27 |
2016-10-06 |
University Of Washington |
Methods for treatment of retinal disease by photoreceptor gene expression modulation
|
|
US20180140722A1
(en)
|
2015-04-06 |
2018-05-24 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for treatment of heart failure
|
|
EP3108883A1
(en)
*
|
2015-06-22 |
2016-12-28 |
Fundació Institut de Recerca Biomèdica de Bellvitge |
Therapeutic uses of non-peptide inhibitors of the calcineurin - nfat signalling pathway
|
|
WO2017007612A1
(en)
|
2015-07-07 |
2017-01-12 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
CA2994969A1
(en)
|
2015-08-06 |
2017-02-09 |
Dana-Farber Cancer Institute, Inc. |
Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses
|
|
US9630049B2
(en)
|
2015-09-21 |
2017-04-25 |
Joseph D Hartman |
Reciprocating rehabilitation device
|
|
US20170100396A1
(en)
|
2015-10-07 |
2017-04-13 |
F. Hoffmann-La Roche Ag |
Pyrrolopyrazine derivatives for use in the treatment, amelioration or prevention of influenza
|
|
HUE067449T2
(hu)
|
2015-10-15 |
2024-10-28 |
Servier Lab |
Ivozidenib, citarabin és daunorubicin vagy idarubicin kombinációs terápa akut mielogén leukémia kezelésére
|
|
US12282014B2
(en)
|
2015-11-19 |
2025-04-22 |
Dana-Farber Cancer Institute, Inc. |
Methods of identifying compounds that interfere with ERG-driven misguidance of BAF complexes in TMPRSS2-ERG driven prostate cancers
|
|
US12233060B2
(en)
|
2016-01-08 |
2025-02-25 |
The Institute Of Cancer Research: Royal Cancer Hospital |
Inhibitors of Ataxia-Telangiectasia Mutated and Rad3-related protein kinase (ATR) for use in methods of treating cancer
|
|
CA3015753A1
(en)
|
2016-02-26 |
2017-08-31 |
Celgene Corporation |
Idh2 inhibitors for the treatment of haematological maligancies and solid tumours
|
|
GB201604638D0
(en)
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
|
WO2017197046A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
C3-carbon linked glutarimide degronimers for target protein degradation
|
|
CN109562113A
(zh)
|
2016-05-10 |
2019-04-02 |
C4医药公司 |
用于靶蛋白降解的螺环降解决定子体
|
|
CN109562107A
(zh)
|
2016-05-10 |
2019-04-02 |
C4医药公司 |
用于靶蛋白降解的杂环降解决定子体
|
|
US10207998B2
(en)
|
2016-09-29 |
2019-02-19 |
Duke University |
Substituted benzimidazole and substituted benzothiazole inhibitors of transforming growth factor-β kinase and methods of use thereof
|
|
WO2018064589A1
(en)
|
2016-09-29 |
2018-04-05 |
Dana-Farber Cancer Institute, Inc. |
Targeted protein degradation using a mutant e3 ubiquitin ligase
|
|
US12023385B2
(en)
|
2017-02-08 |
2024-07-02 |
Dana-Farber Cancer Institute, Inc. |
Tunable endogenous protein degradation with heterobifunctional compounds
|
|
KR20190140438A
(ko)
|
2017-02-28 |
2019-12-19 |
에피자임, 인코포레이티드 |
암 치료를 위한 smarca2의 저해
|
|
EP3601326A4
(en)
|
2017-03-20 |
2020-12-16 |
The Broad Institute, Inc. |
COMPOUNDS AND METHODS OF REGULATING INSULIN SECRETION
|
|
KR20200043433A
(ko)
|
2017-08-21 |
2020-04-27 |
메르크 파텐트 게엠베하 |
아데노신 수용체 길항제로서의 벤즈이미다졸 유도체
|
|
WO2019040098A1
(en)
|
2017-08-21 |
2019-02-28 |
Dana-Farber Cancer Institute, Inc. |
METHODS OF MODULATING THE INTERACTION BETWEEN BAF COMPLEXES AND EWS-FLI1
|
|
CN111601799B
(zh)
|
2018-01-15 |
2023-06-09 |
Ucb生物制药有限责任公司 |
作为Il-17调节剂的稠合咪唑衍生物
|
|
EP3740482A1
(en)
|
2018-01-17 |
2020-11-25 |
Migal Galilee Research Institute Ltd. |
New methionine metabolic pathway inhibitors
|
|
EP3746124A4
(en)
|
2018-01-30 |
2021-10-27 |
Foghorn Therapeutics Inc. |
COMPOUNDS AND THEIR USES
|
|
CN112236172A
(zh)
|
2018-01-30 |
2021-01-15 |
福宏治疗公司 |
用于治疗病症的方法和化合物
|
|
WO2019226915A1
(en)
|
2018-05-25 |
2019-11-28 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: dual-targeted rna polymerase inhibitors
|
|
WO2019246430A1
(en)
|
2018-06-21 |
2019-12-26 |
Foghorn Therapeutics Inc. |
Methods of treating disorders
|
|
US20210260171A1
(en)
|
2018-06-21 |
2021-08-26 |
Foghorn Therapeutics Inc. |
Methods of treating disorders
|
|
CN112585136B
(zh)
|
2018-08-17 |
2024-06-25 |
诺华股份有限公司 |
作为smarca2/brm atp酶抑制剂的脲化合物和组合物
|
|
US20210171958A1
(en)
|
2018-08-23 |
2021-06-10 |
Foghorn Therapeutics Inc. |
Methods of treating cancer
|
|
US12473334B2
(en)
|
2018-10-17 |
2025-11-18 |
Dana-Farber Cancer Institute, Inc. |
SWI/SNF family chromatin remodeling complexes and uses thereof
|
|
WO2020081556A2
(en)
|
2018-10-17 |
2020-04-23 |
Dana-Farber Cancer Institute, Inc. |
Non-canonical swi/snf complex and uses thereof
|
|
EP3883580A4
(en)
|
2018-11-21 |
2023-01-04 |
Foghorn Therapeutics Inc. |
Methods of treating cancers
|
|
MX2021006421A
(es)
|
2018-12-19 |
2021-08-16 |
Leo Pharma As |
Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17).
|
|
US12384776B2
(en)
|
2019-01-29 |
2025-08-12 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
US12509453B2
(en)
|
2019-01-29 |
2025-12-30 |
Foghorn Therapeutics Inc. |
BRM/BRG1 inhibitors and uses thereof
|
|
AU2020214308A1
(en)
|
2019-01-29 |
2021-08-12 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
JP2022525149A
(ja)
|
2019-03-20 |
2022-05-11 |
スミトモ ダイニッポン ファーマ オンコロジー， インコーポレイテッド |
ベネトクラクスが失敗した急性骨髄性白血病（ａｍｌ）の処置
|
|
CA3150354A1
(en)
|
2019-09-12 |
2021-03-18 |
Muralidhara Ramachandra |
METHOD FOR IDENTIFYING RESPONDERS TO SMARCA2/4 DEGRADATION AGENTS
|
|
WO2021081032A1
(en)
|
2019-10-25 |
2021-04-29 |
Dana-Farber Cancer Institute, Inc. |
Compositions comprising modified smarcb1 and uses thereof
|
|
EA202192101A1
(ru)
|
2019-11-21 |
2021-12-09 |
Фогхорн Терапьютикс Инк. |
Соединения и их применение
|
|
BR112022015109A2
(pt)
|
2020-01-29 |
2022-11-08 |
Foghorn Therapeutics Inc |
Compostos e usos dos mesmos
|
|
MX2022009308A
(es)
|
2020-01-29 |
2022-08-22 |
Foghorn Therapeutics Inc |
Compuestos y usos de estos.
|
|
WO2021155264A1
(en)
|
2020-01-29 |
2021-08-05 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
IL295176A
(en)
|
2020-01-29 |
2022-09-01 |
Foghorn Therapeutics Inc |
compounds and their uses
|
|
WO2021155262A1
(en)
|
2020-01-29 |
2021-08-05 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
BR112022015110A2
(pt)
|
2020-01-29 |
2022-11-08 |
Foghorn Therapeutics Inc |
Compostos e usos dos mesmos
|
|
US20250283871A1
(en)
|
2020-03-13 |
2025-09-11 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating the interaction between ss18-ssx fusion oncoprotein and nucleosomes
|
|
US12383555B2
(en)
|
2020-05-20 |
2025-08-12 |
Foghorn Therapeutics Inc. |
Methods of treating cancers
|
|
WO2021236080A1
(en)
|
2020-05-20 |
2021-11-25 |
Foghorn Therapeutics Inc. |
Methods of treating cancers
|
|
US12606553B2
(en)
|
2021-03-09 |
2026-04-21 |
Foghorn Therapeutics Inc. |
Crystalline forms, compositions containing same, and methods of their use
|
|
WO2022192621A1
(en)
|
2021-03-12 |
2022-09-15 |
Celgene Corporation |
Methods for using a hypomethylating agent to treat diseases and disorders based on gene mutation profiles
|
|
WO2022198043A1
(en)
|
2021-03-19 |
2022-09-22 |
Foghorn Therapeutics Inc. |
Therapeutic regimens of an inhibitor of the enzymatic activity of brg1 and brm
|
|
US20240374605A1
(en)
|
2021-07-29 |
2024-11-14 |
Foghorn Therapeutics Inc. |
Methods of treating cancer
|
|
WO2023196560A1
(en)
|
2022-04-08 |
2023-10-12 |
Foghorn Therapeutics Inc. |
Methods of treating cancer
|
|
WO2023196567A2
(en)
|
2022-04-08 |
2023-10-12 |
Foghorn Therapeutics Inc. |
Methods of treating a subject having clinically significant signs and symptoms associated with blood cell differentiation
|
|
US20250339441A1
(en)
|
2022-04-08 |
2025-11-06 |
Foghorn Therapeutics Inc. |
Methods of treating cancer
|
|
WO2024024428A1
(ja)
|
2022-07-29 |
2024-02-01 |
株式会社Soken |
電力変換装置
|
|
CN218451564U
(zh)
|
2022-08-09 |
2023-02-07 |
宁波立奇电器有限公司 |
一种双锅双风道式空气炸锅
|
|
WO2024086577A1
(en)
|
2022-10-17 |
2024-04-25 |
Foghorn Therapeutics Inc. |
Methods of reducing or preventing metastases
|
|
WO2024216151A1
(en)
|
2023-04-13 |
2024-10-17 |
Foghorn Therapeutics Inc. |
Combination therapy for treating hematological cancers
|
|
WO2024216136A1
(en)
|
2023-04-13 |
2024-10-17 |
Foghorn Therapeutics Inc. |
Combination therapy for the treatment of hematological cancers
|